KR20010005746A - 화학적, 열적으로 안정적인 노라스테미졸 조성물 - Google Patents

화학적, 열적으로 안정적인 노라스테미졸 조성물 Download PDF

Info

Publication number
KR20010005746A
KR20010005746A KR1019997008817A KR19997008817A KR20010005746A KR 20010005746 A KR20010005746 A KR 20010005746A KR 1019997008817 A KR1019997008817 A KR 1019997008817A KR 19997008817 A KR19997008817 A KR 19997008817A KR 20010005746 A KR20010005746 A KR 20010005746A
Authority
KR
South Korea
Prior art keywords
lactose
pharmaceutically acceptable
pharmaceutical composition
nolastemizol
composition
Prior art date
Application number
KR1019997008817A
Other languages
English (en)
Korean (ko)
Inventor
마틴피. 레드몬
할티. 버틀러
스테판에이. 왈드
Original Assignee
더글라스이.리디치
세프라코 아이엔시.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더글라스이.리디치, 세프라코 아이엔시. filed Critical 더글라스이.리디치
Publication of KR20010005746A publication Critical patent/KR20010005746A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019997008817A 1997-03-26 1998-03-25 화학적, 열적으로 안정적인 노라스테미졸 조성물 KR20010005746A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US8/824,477 1997-03-26
US85178697A 1997-05-06 1997-05-06
US8/851,786 1997-05-06
PCT/US1998/005701 WO1998042379A2 (en) 1997-03-26 1998-03-25 Chemically and thermally stable norastemizole formulations

Publications (1)

Publication Number Publication Date
KR20010005746A true KR20010005746A (ko) 2001-01-15

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019997008817A KR20010005746A (ko) 1997-03-26 1998-03-25 화학적, 열적으로 안정적인 노라스테미졸 조성물

Country Status (13)

Country Link
EP (1) EP1035869A1 (es)
JP (1) JP2002512614A (es)
KR (1) KR20010005746A (es)
CN (1) CN1257431A (es)
AR (1) AR012187A1 (es)
BR (1) BR9808428A (es)
CA (1) CA2284705A1 (es)
HU (1) HUP0001823A3 (es)
NO (1) NO994655L (es)
NZ (3) NZ527200A (es)
RU (1) RU2214245C2 (es)
WO (1) WO1998042379A2 (es)
ZA (1) ZA982562B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EP2201982A1 (en) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
ES2736155T3 (es) * 2009-08-24 2019-12-26 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Comprimidos de otilonio por compresión directa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232937B1 (en) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2210957T3 (es) * 1992-09-03 2004-07-01 Sepracor Inc. Composiciones farmaceuticas que contienen norastemizol.
JPH11513991A (ja) * 1995-11-17 1999-11-30 ヘキスト・マリオン・ルセル・インコーポレイテツド アレルギー性疾患の治療に有用な置換４−（１ｈ−ベンズイミダゾル−２−イル−アミノ）ピペリジン
ZA977263B (en) * 1996-08-16 1998-02-16 Schering Corp Treatment of upper airway allergic responses.

Also Published As

Publication number Publication date
AU6868098A (en) 1998-10-20
JP2002512614A (ja) 2002-04-23
BR9808428A (pt) 2000-05-23
RU2214245C2 (ru) 2003-10-20
WO1998042379A2 (en) 1998-10-01
WO1998042379A3 (en) 2001-03-01
ZA982562B (en) 1998-10-01
EP1035869A1 (en) 2000-09-20
AR012187A1 (es) 2000-09-27
CA2284705A1 (en) 1998-10-01
NZ517472A (en) 2003-08-29
HUP0001823A2 (hu) 2001-04-28
NO994655L (no) 1999-11-15
CN1257431A (zh) 2000-06-21
NZ527200A (en) 2004-12-24
NZ527201A (en) 2004-12-24
AU735257B2 (en) 2001-07-05
NO994655D0 (no) 1999-09-24
HUP0001823A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
TW522014B (en) Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
JP4435424B2 (ja) 口腔内で速やかに崩壊する錠剤
EP1218889B1 (en) Controlled release compositions comprising nimesulide
US20060127473A1 (en) Compositions and methods for stabilizing active pharmaceutical ingredients
US20030013740A1 (en) Stable dosage forms of fluoxetine and its enantiomers
US20020173522A1 (en) Pharmaceutical compositions comprising norastemizole
KR20010005746A (ko) 화학적, 열적으로 안정적인 노라스테미졸 조성물
JP6328138B2 (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
AU735257C (en) Chemically and thermally stable norastemizole formulations
WO2012173226A1 (ja) ポリスチレンスルホン酸塩含有医薬製剤
TW200914017A (en) Stable pharmaceutical composition of a water-soluble vinorelbine salt
KR102488167B1 (ko) 피롤카르복사미드의 고형 조성물
CZ340699A3 (cs) Farmaceutický prostředek s obsahem norastemizolu
MXPA99008710A (es) Formulaciones de norastemizol quimica y termicamente estables
AU776837B2 (en) Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
AU2011236040A1 (en) (R,R)-Formoterol in combination with other pharmacological agents

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application